BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38583239)

  • 21. Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma.
    Musha H; Ohtani H; Mizoi T; Kinouchi M; Nakayama T; Shiiba K; Miyagawa K; Nagura H; Yoshie O; Sasaki I
    Int J Cancer; 2005 Oct; 116(6):949-56. PubMed ID: 15856455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8
    Meyiah A; Mahmoodi Chalbatani G; Al-Mterin MA; Malekraeisi MA; Murshed K; Elkord E
    Int Immunopharmacol; 2023 Jun; 119():110207. PubMed ID: 37099940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.
    Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E
    Front Immunol; 2021; 12():778329. PubMed ID: 34975867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
    Cantero-Cid R; Casas-Martin J; Hernández-Jiménez E; Cubillos-Zapata C; Varela-Serrano A; Avendaño-Ortiz J; Casarrubios M; Montalbán-Hernández K; Villacañas-Gil I; Guerra-Pastrián L; Peinado B; Marcano C; Aguirre LA; López-Collazo E
    BMC Cancer; 2018 Oct; 18(1):945. PubMed ID: 30285662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
    Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
    Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model.
    Satooka H; Ishigaki H; Todo K; Terada K; Agata Y; Itoh Y; Ogasawara K; Hirata T
    Sci Rep; 2020 May; 10(1):8414. PubMed ID: 32439888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of the tumor-infiltrating lymphocyte subsets in colorectal cancer.
    Liao Y; Ou J; Deng J; Geng P; Zeng R; Tian Y; Liang H; Ni B; Ruan Z
    Med Oncol; 2013 Dec; 30(4):727. PubMed ID: 24026663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of circulating CXCR3
    Han L; Yang X; Yu Y; Wan W; Lv L; Zou H
    Mod Rheumatol; 2019 May; 29(3):461-469. PubMed ID: 29694256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratumoral Plasmid IL12 Expands CD8
    Telli ML; Nagata H; Wapnir I; Acharya CR; Zablotsky K; Fox BA; Bifulco CB; Jensen SM; Ballesteros-Merino C; Le MH; Pierce RH; Browning E; Hermiz R; Svenson L; Bannavong D; Jaffe K; Sell J; Foerter KM; Canton DA; Twitty CG; Osada T; Lyerly HK; Crosby EJ
    Clin Cancer Res; 2021 May; 27(9):2481-2493. PubMed ID: 33593880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy.
    Chow MT; Ozga AJ; Servis RL; Frederick DT; Lo JA; Fisher DE; Freeman GJ; Boland GM; Luster AD
    Immunity; 2019 Jun; 50(6):1498-1512.e5. PubMed ID: 31097342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer.
    Inamori K; Togashi Y; Fukuoka S; Akagi K; Ogasawara K; Irie T; Motooka D; Kobayashi Y; Sugiyama D; Kojima M; Shiiya N; Nakamura S; Maruyama S; Suzuki Y; Ito M; Nishikawa H
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33755600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer.
    Zahran AM; Rayan A; Zahran ZAM; Mohamed WMY; Mohamed DO; Abdel-Rahim MH; El-Badawy O
    PLoS One; 2022; 17(1):e0262650. PubMed ID: 35051220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.
    Kuwahara T; Hazama S; Suzuki N; Yoshida S; Tomochika S; Nakagami Y; Matsui H; Shindo Y; Kanekiyo S; Tokumitsu Y; Iida M; Tsunedomi R; Takeda S; Yoshino S; Okayama N; Suehiro Y; Yamasaki T; Fujita T; Kawakami Y; Ueno T; Nagano H
    Br J Cancer; 2019 Oct; 121(8):659-665. PubMed ID: 31488881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer Patients.
    Kazama K; Otake J; Satoyoshi T; Shiozawa M; Sugano N; Sato S; Atsumi Y; Kano K; Murakawa M; Maezawa Y; Hashimoto I; Numata M; Oshima T; Yukawa N; Rino Y; Sasada T; Masuda M
    In Vivo; 2020; 34(2):849-856. PubMed ID: 32111794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4
    Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
    Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
    Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
    J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-1 Expression on CD8+CD28- T cells within inflammatory synovium is associated with Relapse: A cohort of Rheumatoid Arthritis.
    Ajam F; Aghaei M; Mohammadi S; Samiei H; Behnampour N; Memarian A
    Immunol Lett; 2020 Dec; 228():76-82. PubMed ID: 33069765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer.
    Saleh R; Taha RZ; Toor SM; Sasidharan Nair V; Murshed K; Khawar M; Al-Dhaheri M; Petkar MA; Abu Nada M; Elkord E
    Cancer Immunol Immunother; 2020 Oct; 69(10):1989-1999. PubMed ID: 32393998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
    Karin N
    Front Immunol; 2020; 11():976. PubMed ID: 32547545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.